megestrol has been researched along with Endometrial Neoplasms in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (38.10) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, H; Wang, H | 1 |
| Ma, AY; Xie, SW; Zhou, JY; Zhu, Y | 1 |
| Chen, A; Ma, D; Yang, H; Yao, Y; Zhao, H | 1 |
| Liu, FS; Liu, JC; Yang, HC | 1 |
| Cao, C; Gong, YJ; Guo, XJ; Li, GT; Li, Z; Shao, HH; Xie, SW; Yang, WJ; Zhong, RH; Zhou, JY; Zhu, Y | 1 |
| Hoekstra, AV; Keh, P; Kim, JJ; Schink, JC | 1 |
| Brockbank, E; Bryant, A; Gallagher, C; Kokka, F; Oram, D | 1 |
| Cruz Guerra, NA; Cuesta Roca, C; Jiménez Cidre, M; Linares Quevedo, A | 1 |
| Ben-Shachar, I; Cohn, DE; Vitellas, KM | 1 |
| Ayhan, A; Bahce, M; Demirol, A; Gurgan, T | 1 |
| Baker, TR; Cornelison, TL; Driscoll, DL; Piver, MS | 1 |
| Abulafia, O; Sherer, DM | 1 |
| Chao, AS; Hsueh, S; Lai, CH; Soong, YK | 1 |
| Bigler, LR; Gams, RA; Spencer, DM; Wilkin, JK | 1 |
| Borruto Caracciolo, G; Caccavale, C; Cardone, A; Di Serio, C; Tolino, A | 1 |
| Rose, PG | 1 |
| Brady, MF; Lentz, SS; Major, FJ; Reid, GC; Soper, JT | 1 |
| Cagliero, E; Goodman, A | 1 |
| Davis, TE; Erban, JK; Krook, JE; Pandya, KJ; Schinella, RA; Weiner, LM; Yeap, BY | 1 |
| Chou, HH; Hsueh, S; Huang, HJ; Lai, CH; Soong, YK; Wang, CB; Wang, CJ | 1 |
| Altaras, M; Beyth, Y; Cohen, I; Cordoba, M; Rosen, D; Shapira, J | 1 |
3 review(s) available for megestrol and Endometrial Neoplasms
| Article | Year |
|---|---|
Hormone therapy as a management strategy for lung metastasis after 5 years of endometrial cancer: A case report and literature review.
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy, Needle; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Hysterectomy; Immunohistochemistry; Lung Neoplasms; Megestrol; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Risk Assessment; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uterine Hemorrhage | 2017 |
Hormonal therapy in advanced or recurrent endometrial cancer.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents, Hormonal; Disease-Free Survival; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Neoplasm Staging; Progestins | 2010 |
The role of MRI in the conservative management of endometrial cancer.
Topics: Adult; Endometrial Neoplasms; Female; Humans; Magnetic Resonance Imaging; Megestrol | 2004 |
4 trial(s) available for megestrol and Endometrial Neoplasms
| Article | Year |
|---|---|
Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Melphalan; Middle Aged; Prospective Studies; Survival Rate | 1995 |
Tamoxifen, megestrol acetate, and beta interferon in endometrial cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Interferon-beta; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1995 |
High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 1996 |
Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Megestrol; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Proportional Hazards Models; Survival Rate; Tamoxifen | 2001 |
14 other study(ies) available for megestrol and Endometrial Neoplasms
| Article | Year |
|---|---|
Megestrol acetate drives endometrial carcinoma cell senescence via interacting with progesterone receptor B/FOXO1 axis.
Topics: Antineoplastic Agents, Hormonal; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cellular Senescence; Endometrial Neoplasms; Female; Forkhead Box Protein O1; Humans; Megestrol; Receptors, Progesterone; Signal Transduction | 2021 |
Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Endometrium; Female; Gene Expression Regulation, Neoplastic; Humans; Megestrol; Mice, Inbred BALB C; Mice, Nude; Norpregnadienes; Repressor Proteins; Up-Regulation; Wnt Proteins | 2017 |
Fertility-preserving treatment of stage IA, well-differentiated endometrial carcinoma in young women with hysteroscopic resection and high-dose progesterone therapy.
Topics: Adult; Antineoplastic Agents, Hormonal; Conservative Treatment; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Megestrol; Pregnancy | 2019 |
Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Endometrial Neoplasms; Estrogen Receptor alpha; Eukaryotic Initiation Factor-4G; Female; Humans; Megestrol; Metformin; Mice, Nude; Norpregnadienes; Phosphorylation; Receptors, Progesterone; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2019 |
Absence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case report.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Contraceptives, Oral, Hormonal; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Humans; Megestrol; Progesterone Congeners; Receptors, Progesterone | 2008 |
[Low-grade sarcoma of the endometrial stroma: late recurrence with ureteral and bladder involvement].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Endometrial Neoplasms; Female; Hematuria; Humans; Hydronephrosis; Hysterectomy; Megestrol; Middle Aged; Palliative Care; Radioisotope Teletherapy; Radiotherapy, Adjuvant; Sarcoma, Endometrial Stromal; Thrombophilia; Time Factors; Ureteral Neoplasms; Urinary Bladder Neoplasms | 2002 |
Pregnancy following intracytoplasmic sperm injection and preimplantation genetic diagnosis after the conservative management of endometrial cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Male; Megestrol; Pregnancy; Pregnancy Outcome; Preimplantation Diagnosis; Sperm Injections, Intracytoplasmic | 2005 |
Recurrent transient superior vena cava-like syndrome possibly associated with megestrol acetate.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Hysterectomy; Megestrol; Neoplasm Metastasis; Neoplasm Staging; Ovariectomy; Recurrence; Superior Vena Cava Syndrome | 1995 |
Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma.
Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Pregnancy; Tamoxifen | 1994 |
Uterine adenocarcinoma metastatic to the skin responsive to megestrol acetate.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Drug Resistance; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Skin Neoplasms | 1994 |
Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
Topics: Adenocarcinoma; Adenoma; Antineoplastic Agents; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hyperglycemia; Insulin; Megestrol; Megestrol Acetate; Middle Aged | 1996 |
Megestrol-induced clinical adrenal insufficiency.
Topics: Adenocarcinoma; Adrenal Glands; Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cushing Syndrome; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Megestrol; Prednisone; Treatment Outcome | 2000 |
Fertility-preserving treatment in young patients with endometrial adenocarcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Disease Progression; Endometrial Neoplasms; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Megestrol; Megestrol Acetate; Pelvis; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Ultrasonography | 2002 |
Endometrial decidual changes in a postmenopausal woman treated with tamoxifen and megestrol acetate.
Topics: Adult; Breast Neoplasms; Endometrial Neoplasms; Endometrium; Female; Humans; Megestrol; Menopause, Premature; Polyps; Tamoxifen | 1992 |